🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Hakan Aksoy

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

N/A
0Author DataRank · unranked

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 1 paper. Top paper: “Development of Heart Failure After Initiation of Osimertinib Treatment for Epidermal Growth Factor Receptor (EGFR)-Mutant Adenocarcinoma of the Lung”.

Development of Heart Failure After Initiation of Osimertinib Treatment for Epidermal Growth Factor Receptor (EGFR)-Mutant Adenocarcinoma of the Lung

The American Journal of Cardiology(2018)10.1016/j.amjcard.2018.03.348
N/A
0.269DataRank · unranked
5 citations

Begum Yetis Sayin, Hakan Aksoy, Ali Oto, Sercan Okutucu